Article ID Journal Published Year Pages File Type
8790034 Urologic Oncology: Seminars and Original Investigations 2018 11 Pages PDF
Abstract
Pretreatment identification of MS and INF alterations might represent an available and easy tool for better prognostication of patients with mCRPC. A prospective evaluation is warranted.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Oncology
Preview
Association among metabolic syndrome, inflammation, and survival in prostate cancer
Authors
, , , , , , , , , , , , , , , ,